Volgen
Sagar Rakshit
Sagar Rakshit
Onbekend partnerschap
Geverifieerd e-mailadres voor mayo.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials
M Khunger, S Rakshit, V Pasupuleti, AV Hernandez, P Mazzone, ...
Chest 152 (2), 271-281, 2017
4272017
Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas
N Beig, M Khorrami, M Alilou, P Prasanna, N Braman, M Orooji, S Rakshit, ...
Radiology 290 (3), 783-792, 2019
2762019
Programmed cell death 1 (PD-1) ligand (PD-L1) expression in solid tumors as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors: a systematic review and meta-analysis
M Khunger, AV Hernandez, V Pasupuleti, S Rakshit, NA Pennell, ...
JCO Precision Oncology 1, 1-15, 2017
1352017
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
M Khunger, PD Patil, A Khunger, M Li, B Hu, S Rakshit, A Basu, N Pennell, ...
PloS one 13 (10), e0197743, 2018
692018
Safety and efficacy of PD-1/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non–small-cell lung cancer: a systematic review and meta-analysis
M Khunger, P Jain, S Rakshit, V Pasupuleti, AV Hernandez, J Stevenson, ...
Clinical lung cancer 19 (3), e335-e348, 2018
622018
Extramedullary disease in multiple myeloma
R Bansal, S Rakshit, S Kumar
Blood cancer journal 11 (9), 161, 2021
572021
An integrated segmentation and shape‐based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT
M Alilou, N Beig, M Orooji, P Rajiah, V Velcheti, S Rakshit, N Reddy, ...
Medical physics 44 (7), 3556-3569, 2017
542017
Ipilimumab-induced colitis in patients with metastatic melanoma
KM De Felice, A Gupta, S Rakshit, S Khanna, LA Kottschade, HD Finnes, ...
Melanoma research 25 (4), 321-327, 2015
542015
Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology
JM Dolezal, A Srisuwananukorn, D Karpeyev, S Ramesh, S Kochanny, ...
Nature communications 13 (1), 6572, 2022
492022
Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas
M Alilou, M Orooji, N Beig, P Prasanna, P Rajiah, C Donatelli, V Velcheti, ...
Scientific reports 8 (1), 15290, 2018
322018
Combination of computer extracted shape and texture features enables discrimination of granulomas from adenocarcinoma on chest computed tomography
M Orooji, M Alilou, S Rakshit, N Beig, MH Khorrami, P Rajiah, R Thawani, ...
Journal of Medical Imaging 5 (2), 024501-024501, 2018
312018
Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials.
M Khunger, V Pasupuleti, S Rakshit, P Jain, PJ Mazzone, J Stevenson, ...
Journal of Clinical Oncology 35 (15_suppl), e20647-e20647, 2017
292017
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer
M Mady, K Prasai, SH Tella, S Yadav, CL Hallemeier, S Rakshit, ...
HPB 22 (10), 1490-1495, 2020
212020
Premature clinical trial discontinuation in the era of immune checkpoint inhibitors
M Khunger, S Rakshit, AV Hernandez, V Pasupuleti, K Glass, MD Galsky, ...
The Oncologist 23 (12), 1494-1499, 2018
202018
Immunotherapy in patients with autoimmune disease
S Rakshit, JR Molina
Journal of Thoracic Disease 12 (11), 7032, 2020
172020
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report
A Desai, S Rakshit, R Bansal, Y Ashara, A Potter, R Manochakian, Y Lou, ...
Cancer Treatment and Research Communications 36, 100743, 2023
102023
Pre-treatment hematological markers as a predictive biomarker for survival in patients with non-small cell lung cancer treated with nivolumab.
PD Patil, M Khunger, S Rakshit, J Stevenson, NA Pennell, P Elson, ...
Journal of Clinical Oncology 35 (15_suppl), 11547-11547, 2017
102017
Meta-analysis of tumor PD-L1 expression as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors in solid tumors.
M Khunger, S Rakshit, KA Schalper, P Elson, NA Pennell, J Stevenson, ...
Journal of Clinical Oncology 34 (15_suppl), 11603-11603, 2016
102016
Correlation of somatostatin receptor 2 expression, 68Ga-DOTATATE PET scan and octreotide treatment in thymic epithelial tumors
AC Roden, S Rakshit, GB Johnson, SM Jenkins, AS Mansfield
Frontiers in Oncology 12, 823667, 2022
92022
Computerized analysis of computed tomography (CT) imagery to quantify tumor infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC)
A Madabhushi, V Velcheti, M Orooji, S Rakshit, M Alilou, N Beig
US Patent 10,346,975, 2019
72019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20